STAT

‘We have entered a new era’: Cancer researchers no longer follow a single path to discovery

At a STAT panel, experts highlighted the tantalizing ways in which scientists hope to make progress against cancer, even as steep challenges remain.
Prostate cancer cells seen under the microscope.

CAMBRIDGE, Mass. — Blocking tumor progression. Developing liquid biopsies. Engaging patients to find personalized treatments.

They are all tantalizing ways in which scientists hope to make progress against cancer, a panel of experts noted Wednesday, even as steep challenges remain and the conversation around treatment evolves.

“We have entered a new era,” said Tyler

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT1 min read
STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related